The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 4.8 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Snehjeev Ventures Pvt Ltd, along with Persons Acting in Concert (Rushanks Slunkad, Snehal Lunkad, Riddhi Lunkad), has disclosed acquisition of 560,000 equity shares (0.85%) of Amerise Biosciences Ltd through open market purchase. The acquisition was completed on 24-04-2026, when the 5% holding threshold was crossed. Before the acquisition, the acquirer held 2,969,664 shares (4.49%). After the acquisition, total holding increased to 3,529,664 shares representing 5.34% of total voting capital. The acquirer has confirmed they do not belong to the Promoter/Promoter group of the target company.
This filing indicates a non-promoter investor building a stake beyond the 5% regulatory threshold, which triggers open offer obligations if they exceed 25%. Shareholders should monitor for further accumulation as this could signal a potential change in control or takeover interest.